Advanced Enzyme Technologies Ltd

Advanced Enzyme Techs is a research driven company with global leadership in the manufacturing of enzymes and probiotics.(Source : 201903 Annual Report Page No: 04)

  • Market Cap: 1,776 Cr.
  • Current Price: 159.00
  • 52 weeks High / Low 225.00 / 142.00
  • Book Value: 66.60
  • Stock P/E: 13.64
  • Dividend Yield: 0.38 %
  • ROCE: 24.99 %
  • ROE: 17.97 %
  • Sales Growth (3Yrs): 12.71 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 2.00
Pros:
Company has reduced debt.
Company is virtually debt free.
Cons:
The company has delivered a poor growth of 11.94% over past five years.
Promoter holding has decreased by -8.64% over last 3 years.

Peer Comparison Sector: Chemicals // Industry: Chemicals

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019
85 75 99 108 109 104 103 102 110 110 111 112
52 46 58 63 60 56 61 60 61 57 64 59
Operating Profit 34 30 41 45 48 48 42 42 50 53 47 53
OPM % 40% 39% 42% 42% 45% 46% 41% 41% 45% 48% 42% 47%
Other Income 1 0 0 0 1 0 2 0 3 1 2 1
Interest 1 1 1 1 4 1 2 -0 1 1 1 1
Depreciation 4 4 5 5 5 5 5 5 5 6 6 6
Profit before tax 30 25 36 39 40 42 37 37 46 47 42 47
Tax % 28% 34% 37% 32% 29% 26% 29% 31% 28% 28% 23% 26%
Net Profit 22 16 22 27 27 30 26 24 32 33 31 34
EPS in Rs 1.79 1.46 1.96 2.26 2.44 2.66 2.21 2.19 2.89 2.99 2.77 3.01
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
116 171 219 239 222 293 329 391 420 444
93 109 130 189 131 155 177 226 236 241
Operating Profit 23 62 90 50 91 138 152 165 184 203
OPM % 20% 36% 41% 21% 41% 47% 46% 42% 44% 46%
Other Income 4 3 4 1 1 -3 3 1 5 6
Interest 3 12 10 13 9 8 4 9 5 3
Depreciation 5 6 8 10 9 9 13 18 21 24
Profit before tax 19 48 76 28 74 118 137 139 162 182
Tax % 10% 29% 34% 23% 31% 35% 32% 33% 28%
Net Profit 17 33 49 20 50 76 92 90 111 130
EPS in Rs 1.61 3.18 4.47 1.83 4.57 6.90 8.20 8.07 9.95 11.66
Dividend Payout % 6% 1% 7% 6% 4% 3% 5% 6% 6%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:11.94%
3 Years:12.71%
TTM:6.30%
Compounded Profit Growth
10 Years:%
5 Years:40.75%
3 Years:12.35%
TTM:21.39%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:-20.83%
1 Year:-0.66%
Return on Equity
10 Years:%
5 Years:21.78%
3 Years:19.50%
Last Year:17.97%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
21 21 22 22 22 22 22 22 22 22
Reserves 42 75 140 145 188 256 442 537 657 721
Borrowings 64 207 186 167 115 101 54 67 35 19
26 48 49 75 93 72 71 106 97 122
Total Liabilities 153 350 396 408 418 452 589 732 811 885
51 204 287 287 287 285 421 491 495 512
CWIP 19 60 2 2 5 7 8 11 10 10
Investments 0 0 0 0 0 0 0 0 111 114
82 86 108 119 126 159 160 230 194 249
Total Assets 153 350 396 408 418 452 589 732 811 885

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
16 49 41 43 54 93 107 116 129
-30 -187 -40 -25 -15 -10 -60 -60 -124
27 128 -3 -20 -37 -63 -65 -2 -43
Net Cash Flow 13 -10 -2 -1 2 21 -18 54 -38

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 28% 26% 12% 25% 37% 32% 26% 25%
Debtor Days 70 70 65 49 61 52 55 55 51
Inventory Turnover 7.28 5.95 5.05 4.32 5.18 5.10 5.43 5.50